CONMED beats by $0.01; guides Q1 and Y05 (CNMD) Reports Q4 (Dec) earnings of $0.49 per share, $0.01 better than the Reuters Estimates consensus of $0.48; revenues rose 20.5% year/year to $161.2 mln vs the $151 mln consensus. Company issues in-line guidance for Q1 (Dec), sees EPS of $0.46-$0.48 vs. Reuters Estimates consensus of $0.46 on revs $156-$160 mln, consensus $156 mln; Y05 $1.86-$1.90, consensus $1.90.